Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature
Authors:
- Fabrizio De LucaFLFabrizio De Luca
- Laura Michelina LosappioLLLaura Michelina Losappio
- Corrado MironeCMCorrado Mirone
- Jan Walter SchroederJSJan Walter Schroeder
- Antonella CitterioACAntonella Citterio
- Maria Gloria AversanoMAMaria Gloria Aversano
- Joseph ScibiliaJSJoseph Scibilia
- Elide Anna PastorelloEPElide Anna Pastorello
Open Access
- 4 October 2017
- journal article
- review article
- Published by Springer Nature in Clinical and Molecular Allergy
- Vol. 15 (1) , 1-8
Abstract
Anticonvulsant hypersensitivity syndrome represents a rare but potentially fatal kind of adverse drug reaction. This clinical picture often hampers the flexibility with which alternative anticonvulsants or even other classes of drugs are prescribed in these patients, negatively affecting the efficacy of treatment and the course of the disease. The aim of this study was to analyse a group of six patients with severe cutaneous drug reactions induced by anticonvulsants and to report which alternative antiepileptic drugs and which drugs of other classes were tolerated. A total of six patients (2 males and 4 females, age 11–73 years) are described in this study. In all the patients the onset of the severe cutaneous drug reactions was 2–4 weeks after initiating the anticonvulsant therapy: 2 out of 6 patients presented with a drug reaction with eosinophilia and systemic symptoms under therapy with phenytoin; 2 out of 6 presented with Stevens–Johnson syndrome under therapy with lamotrigine; and 2 out of 6 presented with a toxic epidermal necrolysis, one of them under therapy with valproic acid, and the other one under therapy with lamotrigine. Alternative anticonvulsants tolerated after the reaction were: clonazepam, levetiracetam, diazepam, delorazepam and lormetazepam. In our cases we observed that non aromatic anticonvulsants and benzodiazepines were well tolerated as alternative treatments in six patients with reactions to aromatic anticonvulsivants and that the risk of hypersensitivity reactions to other drug classes was not increased as compared to general population.Keywords
This publication has 49 references indexed in Scilit:
- Spontaneous adverse event reports of Stevens–Johnson syndrome/toxic epidermal necrolysis: detecting associations with medicationsPharmacoepidemiology and Drug Safety, 2011
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in EuropeansNew England Journal of Medicine, 2011
- Association between HLA‐B*1502 and carbamazepine‐induced severe cutaneous adverse drug reactions in a Thai populationEpilepsia, 2010
- Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature reviewBMC Infectious Diseases, 2010
- The Variable Clinical Picture of Drug-Induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms in Relation to the Eliciting DrugImmunology and Allergy Clinics of North America, 2009
- Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-StudyJournal of Investigative Dermatology, 2008
- Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR StudyJournal of the American Academy of Dermatology, 2008
- Idiosyncratic Adverse Reactions to Antiepileptic DrugsEpilepsia, 2007
- Treatment of Epidermal Necrolysis with High-Dose Intravenous Immunoglobulins (IVIg)Drugs, 2005
- Anticonvulsant Hypersensitivity SyndromeDrug Safety, 1999